- This event has passed.
BioNJ’s Manufacturing Briefing
September 21 @ 8:00 am - 1:30 pm
Join industry experts and FDA’s Peter Marks, M.D., Ph.D, Director, Center for Biologics Evaluation and Research for an overview of lessons learned, what is current versus changing and what the challenges, opportunities and expectations are for the future.
|8:00 a.m. – 8:45 a.m.||Registration & Networking Breakfast|
|8:45 a.m. – 9:00 a.m||Welcome & Opening Remarks
Linda Brown, Vice President, Engagement, BioNJ
|9:00 a.m. – 9:30 a.m.||Overview: Current and Future Horizons in Biopharmaceutical Manufacturing
Andrea Gennari, Associate Partner and Manufacturing Expert, McKinsey & Company
|9:30 a.m. – 10:30 a.m.||Challenges & Case Studies
Mark Brower, Ph.D., Downstream Process Development & Engineering, Principal Scientist, Merck & Co., Inc.
Paul Jorjorian, Head, BioProcess Sciences, Thermo Fisher Scientific
Moderator: Katie Kelleher, Associate Partner, McKinsey & Company
|10:30 a.m. – 11:00 a.m.||Networking Break|
|11:00 a.m. – 11:30 a.m.||Overview: Current and Future Horizons in Cell & Gene Therapy Manufacturing
Alberto Santagostino, Partner, McKinsey & Company
|11:30 a.m. – 12:30 p.m.||Challenges & Case Studies
Paul McCormac, Ph.D., Executive Director, Rare Disease Category Lead, Pfizer Research & Development
Loren Wagner, Head of CAR-T Manufacturing Operations, Celgene
Moderator: Elizabeth Dykes, Engagement Manager, McKinsey & Company
|12:30 p.m. – 1:30 p.m.||Networking Lunch with Keynote
Peter Marks, M.D., Ph.D., Director, Center for Biologics Evaluation and Research, U.S. Food and Drug Administration
Registration is $60 for BioNJ Members and $85 for Future Members. Click here or contact Edie Esposito or EEsposito@BioNJ.org to learn about sponsorship and membership opportunities. Call (609) – 890-3185 with any questions.
Thank You To Our Sponsors
Thank You To Our Host